mesalamine has been researched along with Coronary Heart Disease in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, PR | 1 |
| Svendsen, JH | 1 |
| Høst, NB | 1 |
| Hansen, SH | 1 |
| Haunsø, S | 1 |
1 other study available for mesalamine and Coronary Heart Disease
| Article | Year |
|---|---|
Effect of 5-aminosalicylic acid on myocardial capillary permeability following ischaemia and reperfusion.
Topics: Aminosalicylic Acids; Animals; Capillary Permeability; Coronary Disease; Coronary Vessels; Disease M | 1992 |